UCL?Pfizer to develop stem cell sight therapies

UCL?Pfizer to develop pioneering stem cell sight therapies for age-related macular degeneration (AMD). – UCL has entered into a collaboration with the biopharmaceutical group Pfizer, negotiated by UCL Business, to advance development of stem cell-based therapies for age-related macular degeneration (AMD).

Macular degeneration cases would rise in near future

Existing medical treatments could reduce the expected number of cases of visual impairment and blindness attributable to age-related macular degeneration by as much as 35 percent. – Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.

New gene identified for age related macular degeneration AMD

Researchers looked at a UK sample of patients with AMD and controls, and screened 32 genes potentially involved in the condition. Results suggest an association with the SERPING1 gene. – A new genetic association is established with the eye condition age-related macular degeneration (AMD), revealed by researchers.

Eat oily fish to protect your eyesight in old age

Eating oily fish once weekly may protect eyesight against age-related macular degeneration in old age. – Eating oily fish once a week may reduce age-related macular degeneration (AMD) which is the major cause of blindness and poor vision in adults in western countries and the third cause of global blindness, according to a study published in the American Journal of Clinical Nutrition.

Protein Robo4 may reverse macular degeneration, diabetic retinopathy

Two major eye diseases and leading causes of blindness?age-related macular degeneration and diabetic retinopathy?can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. – Two major eye diseases and leading causes of blindness-age-related macular degeneration and diabetic retinopathy-can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.

Genes involved in inflammation may hold clue to age-related macular degeneration

A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries. – A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries.

Compstatin – new drug for vision loss, macular degeneration

UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. – University of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.

Health Newstrack